carbamates has been researched along with scopolamine hydrobromide in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (25.00) | 18.7374 |
| 1990's | 8 (40.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 1 (5.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, DR; Harris, LW; Lennox, WJ; Solana, RP | 1 |
| MacPhail, RC; Moser, VC | 1 |
| Berry, WK; Davies, DR; Gordon, JJ | 1 |
| Green, RD | 1 |
| Overton, DA | 1 |
| Borroni, E; Da Prada, M; Damsma, G; Giovacchini, C; Jakob-Rötne, R; Mutel, V | 1 |
| Bores, GM; Brooks, KM; Camacho, F; Cunningham, DM; Davis, L; Fishkin, R; Hartman, HB; Li, M; Petko, W; Roehr, J; Rush, DK; Selk, DE; Smith, CP; Vargas, HM; Winslow, JT | 1 |
| Demura, N; Fukaya, H; Iimura, A; Ohara, T; Seno, N; Tanaka, K | 1 |
| Bass, R; Chen, Y; Shohami, E; Weinstock, M | 1 |
| Chen, Y; Constantini, S; Shohami, E; Weinstock, M | 1 |
| Ballard, TM; McAllister, KH | 1 |
| Bejar, C; Wang, RH; Weinstock, M | 2 |
| Fischer, P | 1 |
| MACMILLAN, FS; RELLER, HH; SYNDER, FH | 1 |
| Driguès, N; Sagi, Y; Youdim, MB | 1 |
| Amoroso, S; Cassano, T; Castrignanò, S; Colaianna, M; Cuomo, V; Giustino, A; Steardo, L; Trabace, L | 1 |
| Barocelli, E; Bertoni, S; De Vita, D; Flammini, L; Musella, A; Scipione, L | 1 |
| Chaudhaery, SS; Nath, C; Nazir, A; Roy, KK; Sammi, SR; Saxena, AK; Saxena, G; Shakya, N | 1 |
| Arciniega-Martínez, IM; Camarillo-López, RH; Correa Basurto, J; García-Marín, ID; Hernández Rodríguez, M; Méndez Méndez, JV; Rosales-Hernández, MC; Torres-Ramos, MA | 1 |
20 other study(ies) available for carbamates and scopolamine hydrobromide
| Article | Year |
|---|---|
Effects of subacute pretreatment with carbamate together with acute adjunct pretreatment against nerve agent exposure.
Topics: Animals; Carbamates; Cholinesterase Inhibitors; Female; Guinea Pigs; Lethal Dose 50; Male; Mice; Organothiophosphorus Compounds; Physostigmine; Scopolamine; Soman; Trihexyphenidyl | 1991 |
Cholinergic involvement in the action of formetanate on operant behavior in rats.
Topics: Animals; Carbamates; Conditioning, Operant; Insecticides; Male; Rats; Receptors, Cholinergic; Receptors, Muscarinic; Scopolamine | 1987 |
Protection of animals against soman (1,2,2-trimethylpropyl methylphosphono-fluoridate) by pretreatment with some other organophosphorus compounds, followed by oxime and atropine.
Topics: Amitriptyline; Animals; Atropine; Bromides; Carbamates; Cholinesterase Inhibitors; Diphosphates; Drug Antagonism; Female; Fluorine; Guinea Pigs; Hydroxamic Acids; Isoflurophate; Lethal Dose 50; Nitrates; Nitrophenols; Nitroso Compounds; Organophosphonates; Organophosphorus Compounds; Orphenadrine; Oximes; Parasympatholytics; Physostigmine; Poisoning; Pyridinium Compounds; Rabbits; Rats; Salicylates; Scopolamine; Species Specificity; Sulfonic Acids; Sulfuric Acids; Thiazoles; Time Factors | 1971 |
The effect of denervation on the sensitivity of the superior cervical ganglion of the pithed cat.
Topics: Acetylcholine; Animals; Carbachol; Carbamates; Cats; Denervation; Epinephrine; Ganglia, Autonomic; Muscle Contraction; Nictitating Membrane; Parasympathomimetics; Potassium; Quaternary Ammonium Compounds; Scopolamine; Stimulation, Chemical; Time Factors | 1969 |
State-dependent learning produced by depressant and atropine-like drugs.
Topics: Animals; Atropine; Avoidance Learning; Bemegride; Carbamates; Chlordiazepoxide; Chlorpromazine; Ethanol; Imipramine; Injections, Intraperitoneal; Male; Meprobamate; Pentobarbital; Phenobarbital; Physostigmine; Rats; Scopolamine; Transfer, Psychology; Urethane | 1966 |
A novel acetylcholinesterase inhibitor, Ro 46-5934, which interacts with muscarinic M2 receptors.
Topics: Acetylcholine; Alzheimer Disease; Animals; Carbamates; Cholinesterase Inhibitors; Corpus Striatum; Extracellular Space; Humans; Indoles; Muscarinic Antagonists; Physostigmine; Rats; Receptors, Muscarinic; Scopolamine | 1994 |
Pharmacological activity and safety profile of P10358, a novel, orally active acetylcholinesterase inhibitor for Alzheimer's disease.
Topics: Acetylcholinesterase; Administration, Oral; Alzheimer Disease; Aminopyridines; Animals; Avoidance Learning; Brain; Butyrylcholinesterase; Carbamates; Cholinesterase Inhibitors; Corpus Striatum; Dopamine; Female; Humans; Hypothermia, Induced; Kinetics; Male; Maze Learning; Memory; Mice; Mice, Inbred Strains; Ovariectomy; Prosencephalon; Rats; Rats, Wistar; Scopolamine; Social Behavior; Space Perception; Time Factors | 1997 |
SDZ ENA 713 facilitates central cholinergic function and ameliorates spatial memory impairment in rats.
Topics: Animals; Basal Ganglia; Behavior, Animal; Brain Chemistry; Carbamates; Choline O-Acetyltransferase; Cholinergic Antagonists; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Male; Memory Disorders; Microdialysis; Parasympathetic Nervous System; Phenylcarbamates; Rats; Rats, Wistar; Rivastigmine; Scopolamine; Space Perception | 1997 |
Cerebro-protective effects of ENA713, a novel acetylcholinesterase inhibitor, in closed head injury in the rat.
Topics: Animals; Blood-Brain Barrier; Body Temperature; Brain Edema; Carbamates; Cerebral Cortex; Cholinesterase Inhibitors; Head Injuries, Closed; Hippocampus; Male; Movement; Phenylcarbamates; Rats; Reflex; Rivastigmine; Scopolamine | 1998 |
Rivastigmine, a brain-selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed-head injury in the mouse.
Topics: Animals; Brain Edema; Carbamates; Cholinergic Antagonists; Cholinesterase Inhibitors; Cognition Disorders; Head Injuries, Closed; Male; Maze Learning; Mecamylamine; Memory; Mice; Movement; Movement Disorders; Muscarinic Antagonists; Neuroprotective Agents; Phenylcarbamates; Rivastigmine; Scopolamine | 1998 |
The acetylcholinesterase inhibitor, ENA 713 (Exelon), attenuates the working memory impairment induced by scopolamine in an operant DNMTP task in rats.
Topics: Animals; Carbamates; Cholinesterase Inhibitors; Conditioning, Operant; Dose-Response Relationship, Drug; Male; Memory; Neuroprotective Agents; Phenylcarbamates; Rats; Reaction Time; Rivastigmine; Scopolamine | 1999 |
Effect of rivastigmine on scopolamine-induced memory impairment in rats.
Topics: Animals; Carbamates; Cerebral Cortex; Cholinesterase Inhibitors; Corpus Striatum; Drug Therapy, Combination; Hippocampus; Male; Maze Learning; Memory; Muscarinic Antagonists; Muscle, Skeletal; Phenylcarbamates; Rats; Rats, Sprague-Dawley; Rivastigmine; Scopolamine; Tacrine | 1999 |
Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats.
Topics: Animals; Brain; Carbamates; Cholinesterase Inhibitors; Cholinesterases; Female; Male; Memory; Memory Disorders; Muscarinic Antagonists; Muscle, Skeletal; Myocardium; Orchiectomy; Ovariectomy; Phenylcarbamates; Physostigmine; Rats; Rats, Sprague-Dawley; Rivastigmine; Scopolamine; Sex Factors | 2000 |
Successful treatment of nonanticholinergic delirium with a cholinesterase inhibitor.
Topics: Aged; Carbamates; Cholinesterase Inhibitors; Delirium; Female; Humans; Muscarinic Antagonists; Phenylcarbamates; Rivastigmine; Scopolamine | 2001 |
THE ANTIPERSPIRANT ACTION OF TOPICALLY APPLIED ANTICHOLINERGICS.
Topics: Antiperspirants; Atropine; Biomedical Research; Carbamates; Cholinergic Antagonists; Parasympatholytics; Pharmacology; Rabbits; Research; Scopolamine; Sweating; Toxicology; Urea | 1964 |
The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats.
Topics: Animals; Basal Ganglia; Behavior, Animal; Carbamates; Cholinesterase Inhibitors; Dopamine; Hippocampus; Hyperkinesis; Indans; Levodopa; Lewy Body Disease; Male; Monoamine Oxidase Inhibitors; Motor Activity; Muscarinic Antagonists; Norepinephrine; Phenylcarbamates; Rats; Rats, Sprague-Dawley; Rivastigmine; Scopolamine; Serotonin; Time Factors; Tranylcypromine; Tryptophan | 2005 |
Neurochemical and neurobehavioral effects of ganstigmine (CHF2819), a novel acetylcholinesterase inhibitor, in rat prefrontal cortex: an in vivo study.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Administration, Oral; Alkaloids; Analysis of Variance; Animals; Carbamates; Cholinesterase Inhibitors; Chromatography, High Pressure Liquid; Dopamine; Exploratory Behavior; Extracellular Space; Homovanillic Acid; Male; Memory; Norepinephrine; Prefrontal Cortex; Rats; Rats, Wistar; Scopolamine; Serotonin | 2007 |
4-Aminopyridine derivatives with anticholinesterase and antiamnesic activity.
Topics: 4-Aminopyridine; Amnesia; Animals; Avoidance Learning; Behavior, Animal; Carbamates; Cholinesterase Inhibitors; Kinetics; Rats; Scopolamine | 2008 |
Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: pharmacophore-based virtual screening, synthesis, and pharmacology.
Topics: Acetylcholinesterase; Administration, Oral; Animals; Avoidance Learning; Caenorhabditis elegans; Carbamates; Catalytic Domain; Cholinesterase Inhibitors; Databases, Factual; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Male; Mice; Models, Molecular; Nootropic Agents; Quantitative Structure-Activity Relationship; Scopolamine | 2010 |
Tert-butyl-(4-hydroxy-3-((3-(2-methylpiperidin-yl)propyl)carbamoyl)phenyl)carbamate Has Moderated Protective Activity in Astrocytes Stimulated with Amyloid Beta 1-42 and in a Scopolamine Model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Carbamates; Disease Models, Animal; Humans; Neuroprotective Agents; Peptide Fragments; Rats; Scopolamine | 2020 |